Find The Best Stocks With Perfect Trade Setups In Minutes A Day

Stop wasting time looking for the right stocks.  Free training on how to find perfect stock trades that can move 300-1,500%.  Learn the # 1 key to successful stock investing and how to find success even If the market is crashing, rebounding… or just going sideways. (ad)

Do Not Delay - Click Here Now


This Pot Stock Is Bank Of America’s Top Pick As They Initiate Coverage In The Cannabis Space

Just in time for 420—an annual celebration for marijuana users—Bank of America names this pot stock its top pick in the space and says it could surge 48% higher.

Bank of America analyst Christopher Carey joined a short but growing list of analysts covering the cannabis sector on Wednesday, naming Hexo (NASDAQ: HEXO) its top pick in the space.

Hey, did you know if you really want to retire early, this free training lays it all out for you! Check it out here.

“HEXO is our Top Pick in cannabis, screening compelling in our valuation framework vs peers (EV/sales and DCF), and with fundamentals grounded by the most de-risked cannabis supply in Canada (off-take with Quebec), an innovation-forward organization and potential for additional value-add partnerships (beyond that already developed with Molson Canada),” Carey wrote in a note to clients.

The firm estimates that the Canadian cannabis supply will exceed domestic consumption by 2021. When that happens, BofA expects the market to become more mature which will lead to greater competition for shelf space giving HEXO an advantage with its differentiated products and price deflation.

Carey gave HEXO a Buy rating and set his price target for the stock at $10 – 48% higher than Thursday’s closing price.

He’s also bullish on heavyweights Canopy Growth (NYSE: CGC) and Aurora Cannabis (NYSE: ACB). According to Carey, Canopy’s 6 million square feet of production capacity and its partnership with Constellation Brands (NYSE: STZ) put it in a good position to be a long-term market leader.

As for Aurora, Carey said that it is one of the few cannabis companies working to set up operations globally, which will set it up well to take advantage the growing global legalization of the drug. The company also has yet to enter into a major partnership, which leaves open the possibility of a major bullish catalyst in the future.

Carey issued a Buy rating for Aurora with an $11 price target, 22% higher than the current price. Canopy Growth was initiated with a Buy rating as well and given a price target of $52 – nearly 17% higher than Thursday’s closing price.

The analyst wasn’t as kind to another big name in the cannabis space, however.

He issued an Underperform rating on Cronos (NASDAQ: CRON) and gave it a $13 price target, indicating possible downside of -17%. While Carey likes the company’s fundamentals, its current valuation is a red flag for Carey.

“For Cronos, we expect attractive long-term growth and margins, while also giving credit for the cash from Altria (NYSE: MO),” Carey wrote. “Despite this, the stock still screens the most expensive in our coverage. A key risk to our rating is that Cronos deploys its recently injected capital for deals in geographies or categories the market deems attractive. Otherwise, we don’t see a case for near-term upside.”

By the way, if you liked this article, you'll LOVE this Meaty free training I just published on the top 3 questions and challenges every investor faces AND how to overcome them. It's titled "10k into $2.4 Million in 18 months" and you can grab it for free here

There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses. Information provided by the Company is not investment advice. The Company is not a registered investment adviser, stock broker, or brokerage. You agree that the Company does not represent, warrant, or take responsibility that any account will or is likely to achieve profit or losses similar to those shown. Examples published by the Company are selected for illustrative purposes only. They are not typical and do not represent the typical results of all stocks within the Companys software or its individual scans and searches. No independent party has audited any hypothetical performance contained at this Web site, nor has any independent party undertaken to confirm that they reflect the trading method under the assumptions or conditions specified.

FREE TRADING WEBINAR - TRADERSPRO PRESENTS: Starting With Only $10,000 Retire With $2.4 Million? Click Here Now

Join Us Now